Anthem Biosciences Limited has informed the Exchange regarding 'Intimation Of Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations), 2015'.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed the stock exchanges about the appointment of authorized Key Managerial Personnel responsible for assessing the materiality of corporate events and making disclosures to the exchanges. Ms. Divya Prasad, Company Secretary and Compliance Officer, and Mr. Mohammed Gawir Baig, Chief Financial Officer, have been authorized for this role. The disclosure is filed under Regulation 30(5) of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. This is a routine corporate governance compliance filing and does not involve any business or financial decision.
No direct impact on shareholders or stock price. This is a standard regulatory compliance update confirming who within the company is authorized to make material disclosures to the exchanges.